Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.900 | 0.902 | 122 | 1997 | 2018 | ||||
Obesity
|
1111 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.100 | 0.804 | 46 | 1997 | 2018 | ||||
Diabetes Mellitus
|
824 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.100 | 0.842 | 38 | 1999 | 2018 | ||||
Hyperinsulinism
|
64 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.090 | 1.000 | 9 | 1999 | 2013 | ||||
Diabetes
|
710 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.100 | 0.813 | 32 | 2000 | 2014 | ||||
Impaired glucose tolerance
|
81 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.040 | 1.000 | 4 | 2000 | 2012 | ||||
Metabolic Syndrome X
|
591 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.100 | 0.960 | 25 | 2001 | 2018 | ||||
Hypertensive disease
|
1085 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.070 | 0.714 | 7 | 2001 | 2019 | ||||
Malignant Neoplasms
|
1641 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.070 | 1.000 | 7 | 2001 | 2014 | ||||
Primary malignant neoplasm
|
1374 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.070 | 1.000 | 7 | 2001 | 2014 | ||||
Insulin resistance syndrome
|
15 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.040 | 1.000 | 4 | 2001 | 2002 | ||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||
Dyslipidemias
|
184 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||
obsolete Combined hyperlipidemia
|
4 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||
Renal Cell Carcinoma
|
288 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||
Polycystic Ovary Syndrome
|
363 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.100 | 0.789 | 19 | 2002 | 2019 | ||||
Breast Carcinoma
|
2793 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.070 | 0.857 | 7 | 2002 | 2018 | ||||
Malignant neoplasm of breast
|
3417 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.070 | 0.857 | 7 | 2002 | 2018 | ||||
Lipid Metabolism Disorders
|
10 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.020 | 1.000 | 2 | 2002 | 2016 | ||||
Colorectal Carcinoma
|
1962 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.100 | 0.846 | 13 | 2003 | 2018 | ||||
Cardiovascular Diseases
|
711 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.060 | 0.833 | 6 | 2003 | 2015 | ||||
Myocardial Infarction
|
680 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.050 | 0.600 | 5 | 2003 | 2015 | ||||
Arteriosclerosis
|
267 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 1.000 | 3 | 2003 | 2014 | ||||
Atherosclerosis
|
281 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 1.000 | 3 | 2003 | 2014 | ||||
Malignant neoplasm of prostate
|
1082 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 0.667 | 3 | 2003 | 2015 |